GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » EV-to-FCF

Innovita Biological Technology Co (SHSE:688253) EV-to-FCF : 6.51 (As of Apr. 23, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Innovita Biological Technology Co's Enterprise Value is ¥2,644.8 Mil. Innovita Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥406.2 Mil. Therefore, Innovita Biological Technology Co's EV-to-FCF for today is 6.51.

The historical rank and industry rank for Innovita Biological Technology Co's EV-to-FCF or its related term are showing as below:

SHSE:688253' s EV-to-FCF Range Over the Past 10 Years
Min: 5.32   Med: 13.72   Max: 86.78
Current: 6.18

During the past 6 years, the highest EV-to-FCF of Innovita Biological Technology Co was 86.78. The lowest was 5.32. And the median was 13.72.

SHSE:688253's EV-to-FCF is ranked worse than
55.58% of 448 companies
in the Biotechnology industry
Industry Median: 2.105 vs SHSE:688253: 6.18

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-23), Innovita Biological Technology Co's stock price is ¥32.80. Innovita Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥2.430. Therefore, Innovita Biological Technology Co's PE Ratio (TTM) for today is 13.50.


Innovita Biological Technology Co EV-to-FCF Historical Data

The historical data trend for Innovita Biological Technology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co EV-to-FCF Chart

Innovita Biological Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - - 25.62 7.04

Innovita Biological Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.17 7.04 8.27 8.81 10.17

Competitive Comparison of Innovita Biological Technology Co's EV-to-FCF

For the Biotechnology subindustry, Innovita Biological Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovita Biological Technology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovita Biological Technology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Innovita Biological Technology Co's EV-to-FCF falls into.


;
;

Innovita Biological Technology Co EV-to-FCF Calculation

Innovita Biological Technology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2644.825/406.166
=6.51

Innovita Biological Technology Co's current Enterprise Value is ¥2,644.8 Mil.
Innovita Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥406.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovita Biological Technology Co  (SHSE:688253) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Innovita Biological Technology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.80/2.430
=13.50

Innovita Biological Technology Co's share price for today is ¥32.80.
Innovita Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.430.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Innovita Biological Technology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovita Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071
Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.
Executives
Chen Fu Kang senior management
Zhang Xiao Gang Directors, senior managers
Zhang Xiu Jie Directors, senior managers
Chen Ting You Director, core technical staff
Wang Heng Qiang Core technical personnel
Zhao Xiu Juan Directors, senior managers
Ding Zhi Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines